NCT07644897
- Conditions
- Immune Checkpoint Inhibitor, Immune-related Adverse Event, Melanoma, +11 more
- Locations
-
- Sun yat-sen uniersity Guangzhou, Guangdong, China
- Nanshan hospital Shenzhen, Guangdong, China
Clinical trial condition
Immune-related Adverse Event
Explore clinical trials studying Immune-related Adverse Event. Study availability and eligibility vary by location and protocol.
20 public trials
11 recruiting studies
Immune-related Adverse Event trial results
NCT06860542
- Conditions
- Immune-related Adverse Event, Infections, Lung Diseases, +4 more
- Locations
-
- Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
Recruiting
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
NCT06037811
- Conditions
- Arthritis, Immune-related Adverse Event, Inflammatory Arthritis, +2 more
- Locations
-
- St. Joseph's Health Care London, Ontario, Canada
Recruiting
Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
NCT05663775
- Conditions
- Advanced Melanoma, Advanced Rectal Carcinoma, Diarrhea, +4 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
NCT05813418
- Conditions
- Immune Checkpoint Inhibitors, Immune-related Adverse Event, Immunotherapy, +1 more
- Locations
-
- CHU Amiens Picardie Amiens, Picardie, France
NCT05832606
- Conditions
- Behavior, Behavior, Animal, Dietary Habits, +2 more
- Locations
-
- UZ Brussel Jette, Belgium
Recruiting
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
NCT06613165
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
- Locations
-
- Xijing hospital Xi'an, Shaanxi, China
Recruiting
SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
NCT06278857
- Conditions
- Endometrial Cancer Stage I, Endometrial Neoplasms, Endometrioid Endometrial Adenocarcinoma, +14 more
- Locations
-
- Westmead Hospital Sydney, New South Wales, Australia
- Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
Recruiting
The Effect of Serum Ferritin in irAE
NCT06702566
- Conditions
- Acute Leukemia, Immune-related Adverse Event, Malignant Solid Tumors, +1 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT05700565
- Conditions
- Immune-related Adverse Event
- Locations
-
- LMU Klinikum Hauttumorzentrum Munich, Germany